Biocon Q1 Results preview: PAT expected to fall 47% YoY due to rise in interest expenses
Biocon Q1 Results preview: Biocon's earnings before interest, taxes, depreciation, and amortisation, or EBITDA, are seen at 825 crore, up 132 per cent YoY. It posted an EBITDA of Rs 356 crore in the year-ago quarter.
Biocon Q1 Results preview: Biocon, the biopharmaceutical company based in Bengaluru, is expected to report consolidated revenue of Rs 3,468 crore for the June quarter (Q1FY24), up 62 per cent on a year-on-year (YoY) basis, as per Zee Business Research. The company had posted a revenue of Rs 2,140 crore in the year-ago period. Its PAT (profit after tax), however, is expected to decline 47 per cent YoY to Rs 147 crore as compared to Rs 167 crore logged in the corresponding quarter of the previous fiscal.
The profit will be under pressure due to increasing interest expenses.
Biocon's earnings before interest, taxes, depreciation, and amortisation, or EBITDA, are seen at 825 crore, up 132 per cent YoY. It posted an EBITDA of Rs 356 crore in the year-ago quarter. EBITDA margin is estimated to come in at 24 per cent, up from 17 per cent in the June 2022 quarter.
It must be noted that in November last year, Biocon's subsidiary Biocon Biologics announced the acquisition of the international biosimilars business of Viatris in a deal totalling $3 billion. Biocon's biosimilars segment's income growth is likely to see 2x growth. Its income is expected to reach nearly $252 million. The Generics segment is expected to see 23 per cent growth. Further, the integration of Viatris is also expected to aid growth. Besides, Pegfilgrastim, Trastuzumab, and Insulin Glargine are also expected to see good growth.
Biocon Q4 Results
The company logged a consolidated net profit of Rs 313 crore for the quarter ended March 2023 on the back of robust sales, as against a net profit of Rs 239 crore for the corresponding period a year ago. The company’s revenue grew 58.7 per cent to Rs 3,929 crore for the three-month period, which was estimated at Rs 3,694 crore. The company’s margin — a key measure of profitability for a business — increased to 26 per cent from 24.6 per cent a year ago, which was estimated at 23 per cent.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
SRH vs GT IPL 2024 Ticket Booking Online: Where and how to buy SRH vs GT tickets online - Check IPL Match 66 ticket price, other details
Top 7 SWP Mutual Funds: Rs 50 lakh investment, Rs 70K monthly pension for 10 years, and Rs 42.30 lakh balance value; know more details
Gold and Silver rate today (May 13, 2024): Precious metal under pressure; yellow metal near Rs 72,400, white metal above Rs 84,600
SIP Returns: How Rs 3,000, 5,000, and Rs 10,000 SIPs can help you build retirement corpus of Rs 1.06 cr, Rs 1.77 cr, and Rs 3.53 cr
07:25 PM IST